ANDA 63082, held by Watson Labs. Clindamycin Hydrochloride.
As of Nov 16, 2026, ANDA 63082 (Clindamycin Hydrochloride), held by Watson Labs, was first approved by FDA on Jul 31, 1991, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin HydrochlorideEQ 75MG BASE ยท capsule;oral | Clindamycin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters